Indivior posts updated corporate presentation June 2025; content not fully disclosed

Indivior Pharmaceuticals, Inc.

Company added 'Corporate Presentation June 2025' to its investor relations website on June 2, 2025.
Presentation furnished as Exhibit 99.1; full text not provided in SEC filing excerpt.
No specific financial guidance, clinical data, or operational updates available from truncated exhibit.
Investors should refer to the full presentation on Indivior's IR page for details.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.